EP Patent

EP2897592A2 — Pharmaceutical compositions having improved storage stability

Assigned to Alkermes Pharma Ireland Ltd · Expires 2015-07-29 · 11y expired

What this patent protects

The present invention relates to a pharmaceutical composition that provides long-term stability of a hydrolytically labile antipsychotic agent

USPTO Abstract

The present invention relates to a pharmaceutical composition that provides long-term stability of a hydrolytically labile antipsychotic agent

Drugs covered by this patent

Aristada (ARIPIPRAZOLE LAUROXIL) · Alkermes Inc

Patent Metadata

Patent number: EP2897592A2
Jurisdiction: EP
Classification: —
Expires: 2015-07-29
Drug substance claim: No
Drug product claim: No
Assignee: Alkermes Pharma Ireland Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.